Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. Show more
Rue Edouard Belin 12, Mont-Saint-Guibert, 1435, Belgium
Market Cap
122.7M
52 Wk Range
$2.72 - $8.64
Previous Close
$2.81
Open
$2.81
Volume
18,282
Day Range
$2.78 - $2.94
Enterprise Value
131.8M
Cash
25.93M
Avg Qtr Burn
-21.56M
Insider Ownership
37.04%
Institutional Own.
21.86%
Qtr Updated
03/31/26
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|